Key Conference Highlights:
The latest market trends in recent economy recession from global perspective. The incentive program that Taiwanese government will launch in response to this crisis will be also highlighted and discussed.
Exploring the trends, paths and approaches to entering China market and elaborate the opportunities in cross strait biotech development.
The opportunities for the win-win partnerships by pre-screened match making. 2 days of networking opportunities at this Conference.
The stage to showcase the emerging technologies to potential investors and industry executives

July 21 (Tuesday)
08:30 - 09:00 Registration
09:00 - 09:30 Opening Ceremony
Opening Remarks
on Taiwan's Biotech Development Initiatives
Session I: Biotech Global Trend
Session Chair: Dr. Chia-Lin Jeff Wang, President, Development Center for Biotechnology
09:30 - 10:05 Knowledge Synergies ¡V A New Paradigm of Innovation
Mr. Israel Makov, Chairman, Given Imaging Ltd.
¡@¡@¡@¡@¡@¡@¡@Chairman, Netafim Ltd.
10:05 - 10:30 Morning Refreshment & Networking
10:30 - 11:05 A Paradigm Shift in Healthcare: Changing Business Models and the Impact of Technology
Ms. Reenita Das, Senior Vice President, Asia Pacific, Healthcare, Frost & Sullivan
11:05 - 11:40 The Next Commercial Revolution for Biotechnology
Dr. John Hamer, Managing Director, Burrill & Company
11:40 - 12:15 In Search of Innovation in Asia
Dr. Frank Grams, Executive Director, Roche Global Pharma Partnering, Asia
12:15 - 13:45
 Luncheon
The Current Status and Perspective of Agricultural Technology Licensing in Taiwan
Dr. Tzu-Bin Huang, Director General, Department of Science and Technology, Council of Agriculture, Executive Yuan
Session II: Investor and Business Partnering
Investor Forum: Exploring Trends, Paths and Opportunities in Greater China
Session Chair: Dr. Marietta Wu, General Manager, Greater China, Burrill & Company
13:45 - 13:50 Moderator Remarks and Introduction
13:50 - 14:50
Presentation - Investor perspective with a focus on investing
 
  • Taiwan ¡V A Launch Pad to China and Other Asian Countries
    ¡@  Dr. Marietta Wu, General Manager, Greater China, Burrill & Company
  • Investment Opportunities in Asia, Particularly in China and Taiwan
    ¡@  Dr. Nancy Chang, Chairman and Senior Managing Director, Asia, OrbiMed
    ¡@  Adivosors
  • Life Science Venture Investment and Partnering Opportunities in China
    ¡@  Dr. Frank Kung, Managing Partner, Vivo Ventures
  • General Introduction of IP Status in China; Impact of Change of the Law;
    ¡@ China Related Issues on Investing and Licensing(TBD)
    ¡@  Dr. James Zhu, Beijing Managing Partner, Perkins Coie LLP
    		•
    14:50 - 15:20
    Presentation - Company perspective with a focus on partnership
     
  • Maintaining a Competitive Edge via Partnering in a Changing Landscape
    ¡@  Dr. Jennifer Hu, Director, Licensing & External Research, Merck Sharp & Dohme
  • Partnership Strategy for Asian Biotech
    ¡@  Mr. George Yeh, President, Taiwan Liposome Company Ltd.
    		•
    15:20 - 15:50 Networking Refreshment Break & Exhibition
    15:50 - 17:20
    Panel Discussion
     
  • Elaborate the opportunities in cross strait biotech development
  • Discuss and analyze the latest trends in partnering and provide insights into
    ¡@ successful alliance formation
  • Provide a successful approach to enter this dynamic market
    		•
    17:20 - 18:00 Cocktail Reception & Exhibition
    18:00 Dinner Banquet
    July 22 (Wednesday)
    Session III:Successful Business Model and Strategy
    Session Chair: Dr. Frank Grams, Executive Director, Roche Global Pharma Partnering, Asia
    09:00 - 09:10 Moderator Remarks and Introduction
    09:10 - 09:30 From the Bench to the Bedside
    Dr. Dalia Cohen, Chief Scientific Officer, Rosetta Genomics
    09:30 - 09:50 Global Strategic Alliances: a Start-up's Perspective
    Dr. Ming-Chu Hsu, Chairman and CEO, TaiGen Biotechnology Co., Ltd.
    09:50 - 10:10 The Road from NIH SBIR Grants to a Therapeutic Antibody Company
    Dr. Jeng Her, CEO, Protevo Biotech
    10:10 - 10:30 Morning Refreshment & Networking
    10:30 - 10:50 Global Strategic Alliance - A Venture Capitalist's Perspective
    Mr. Antony Paul Bishop, Council member, New Zealand Venture Capital Association
    10:50 - 12:00
    Panel Discussion: Innovative Business Models in Biotech Industry to Overcome the Recent Economic Recession
    Moderator:
    Dr. Dalia Cohen, Chief Scientific Officer, Rosetta Genomics
    Panelists:
    Dr. Frank Grams, Executive Director, Roche Global Pharma Partnering, Asia
    Dr. Ming-Chu Hsu, Chairman and CEO, TaiGen Biotechnology Co., Ltd.
    Dr. Jeng Her, CEO, Protevo Biotech
    Mr. Antony Paul Bishop, Council member, New Zealand Venture Capital Association
    Dr. Axel Polack, General Partner, TVM Capital
    Mr. Tomas Landh, Director Strategy and Sourcing, Diabetes Research Unit, Novo Nordisk A/S
    12:00 - 13:30 Luncheon: Country Highlight
    National Policy: Catalyst to Thailand's Biotechnology Industry
    Prof. Dr. Morakot Tanticharoen, Vice President of NSTDA and Senior Advisor to BIOTEC
    Session IV: Business-to-Business Partnering
    13:30 - 16:30 Company Presentation - Biotech Investment Opportunities
    24 biotech companies from USA, Germany, Austria, Taiwan, China, Netherlands, Thailand, Denmark, etc. will present their Corporate and R&D overview. It is a supreme opportunity for biotech companies, the major VC's, and investors from all over the world to meet one on one.
    16:30 - 17:30 One-on-One Meetings
    17:30 Adjournment

    website design / webhosting by fansio